. Author manuscript; available in PMC: 2012 Dec 1.

Published in final edited form as: J Investig Med. 2011 Dec;59(8):1239–1243. doi: 10.231/JIM.0b013e31823548e8

Table 1.

Baseline clinical characteristics of patients with abdominal aortic aneurysm treated with and without statins.

Variable	Statins Users (n=136)	Non-users (n=75)	p-value
Male	91 (67%)	50 (67%)	0.971
Age (± SD)	70 (± 7.88)	69 (± 9.08)	0.450
Initial lesion size (cm)	4.1 (3.7-4.4)	4.1 (3.7-4.3)	0.957
Follow-up (yrs)	1.04 (1.01-1.10)	1.04 (1.02-1.12)	0.286
BMI	27.58 ± 4.88	26.92 ± 4.65	0.333
CAD	55 (41%)	31 (41%)	0.933
DM	32 (24%)	19 (25%)	0.792
PVD	29 (22%)	14 (19%)	0.628
CVA/TIA	33 (24%)	16 (21%)	0.609
CRI	40 (30%)	16 (21%)	0.193
HLP	111 (82%)	53 (71%)	0.052
COPD	87 (64%)	45 (60%)	0.523
HTN	122 (90%)	67 (89%)	0.810
Tobacco use	122 (90%)	65 (87%)	0.410

Abbreviations: BMI, body mass index; CAD, coronary artery disease; DM, diabetes mellitus; PVD, peripheral vascular disease; CVA/TIA, cerebral vascular attack or transient ischemic attack; CRI, chronic renal insufficiency; HLP, hyperlipidemia; COPD, chronic obstructive pulmonary disease; HTN, hypertension.